Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study was to investigate the efficacy of levalbuterol compared to
a placebo and compared to albuterol in the treatment and prevention of bronchoconstriction in
adolescent and adult subjects with asthma, with all treatments administered 4 times a day
(QID).